| 1. |
- Ansari, David, et al.
(författare)
-
Portal Venous System Thrombosis After Pancreatic Resection
- 2013
-
Ingår i: World Journal of Surgery. - : Springer Science and Business Media LLC. - 1432-2323 .- 0364-2313. ; 37:1, s. 179-184
-
Tidskriftsartikel (refereegranskat)abstract
- Portal venous system thrombosis (PVST) is a rare, potentially fatal complication after pancreatic resection. The aim of this study was to assess the incidence, presenting symptoms, management, and treatment of PVST in a large cohort of patients. Prospectively collected data on patients undergoing pancreatic resection between 1997 and 2009 were reviewed retrospectively. Preoperative and postoperative imaging were analyzed for the presence or absence of venous thrombi. All patients received standard thromboprophylaxis with low-molecular-weight heparin (LMWH). Of 516 pancreatic resections performed, 18 (3.5 %) were complicated by PVST. The most common clinical presentations were abdominal pain (n = 9) and ascites (n = 5) but never any alarm symptoms. Other symptoms were vague and nonspecific (e.g., weight loss, fatigue, fever). Total pancreatectomy was a risk factor compared to hemipancreatectomy (p < 0.01), whereas the underlying disease per se did not make any difference. The median interval between surgery and diagnosis of PVST was 105 days (range 1-1,440 days). PVST was at least a contributing factor in the postoperative deaths of two patients. LMWH therapy did not significantly affect survival. PVST remains a relatively infrequent complication after pancreatic resection. Because accurate diagnosis and timely intervention may reduce morbidity and mortality, the possibility of PVST should be considered in patients presenting with vague symptoms. Whether anticoagulant treatment is needed is still not clear; there were no obvious differences in outcome between treated and untreated patients.
|
|
| 2. |
- Groth, Kristina, et al.
(författare)
-
Efficiency in Treatment Discussions : A Field Study of Time Related Aspects in Multi-Disciplinary Team Meetings
- 2009
-
Ingår i: 2009 22ND IEEE INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS. - 9781424448791 ; , s. 88-95
-
Konferensbidrag (refereegranskat)abstract
- We present a field study of multi-disciplinary team meetings where decisions on treatment of patients with diseases in the upper part of the abdomen are made. These meetings are important for knowledge dissemination and learning. We have studied how different time related aspects affect the efficiency during these meetings. Time is relevant because several physicians attend these meetings, and they have tight schedules as it is. Our analysis focuses on the conversation during the team meetings, and on how aspects such as indistinct discussions, lack of relevant competence and information, and the structuring of medical information affect time efficiency.
|
|
| 3. |
- Tingstedt, Bobby, et al.
(författare)
-
First results from the Swedish National Pancreatic and Periampullary Cancer Registry
- 2019
-
Ingår i: HPB. - : Elsevier BV. - 1365-182X .- 1477-2574. ; 21:1, s. 34-42
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Despite improvements in therapy regimens over the past decades, overall survival rates for pancreatic and periampullary cancer are poor. Specific cancer registries are set up in various nations to regional differences and to enable larger prospective trials. The aim of this study was to describe the Swedish register, including possibilities to improve diagnostic work-ups, treatment, and follow-up by means of the register.Methods: Since 2010, all patients with pancreatic and periampullary cancer (including also patients who have undergone pancreatic surgery due to premalignant or benign lesions) have been registered in the Swedish National Periampullary and Pancreatic Cancer registry.Results: In total 9887 patients are listed in the registry; 8207 of those have malignant periampullary cancer. Approximately one-third (3282 patients) have had resections performed, including benign/premalignant resections. 30-day and 90-day mortality after pancreatoduodenectomy is 1.5% and 3.5%, respectively. The overall 3-year survival for resected pancreatic ductal adenocarcinoma is 35%. Regional variations decreased over the studied period, but still exist.Conclusion: Results from the Swedish National Registry are satisfactory and comparable to international standards. Trends over time show increasing resection rates and some improved results. Better collaboration and openness within pancreatic surgeons is an important side effect.
|
|
